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A corrigendum on
Sustained Contraction in Vascular SmoothMuscle by Activation of L-type Ca2+ Channels Does
Not Involve Ca2+ Sensitization or Caldesmon
by Ets, H. K., and Seow, C.Y. (2016). Front. Pharmacol. 7:516. doi: 10.3389/fphar.2016.00516
Results from our recent publication indicate that sustained contraction in vascular smooth
muscle induced by Bay K8644 is independent from Rho-kinase (ROCK) associated calcium
sensitization. We have failed to recognize and properly acknowledge an earlier study by Alvarez
et al. (2010) that reached the same conclusion. In their study Alvarez et al. clearly demonstrated that
phosphorylation of MYPT1, a downstream substrate of ROCK, was not increased by Bay K8644
activation and therefore the calcium-dependent myosin light chain (MLC) phosphorylation and
the associated sustained tension maintenance cannot be the consequence of Bay K8644-induced
MYPT1 phosphorylation. In our study Bay K8644 also failed to increase MYPT1 phosphorylation,
and in addition we found that phosphorylation of CPI-17, a downstream substrate for PKC and
ROCK, was not changed by Bay K8644 activation either. Taken together, results from both studies
strongly suggest that an increase in intracellular calcium concentration in vascular smooth muscle
does not necessarily lead to activation of ROCK and the associated calcium sensitization.
The concept of calcium sensitization in smooth muscle activation was first described by
Morgan and Morgan (1984). In vascular smooth muscle they found that agonist (phenylephrine)
stimulation, compared with the stimulation by potassium depolarization, led to more force
generation at lower intracellular calcium concentrations. Rembold and Murphy (1988) also
observed a stronger calcium-sensitizing effect of agonist stimulation relative to potassium
depolarization. Furthermore they revealed that the sensitization step occurred in between the
release of calcium and MLC phosphorylation, and not between MLC phosphorylation and force
generation.
The lack of calcium-sensitizing effect of Bay K8644 has also been recognized by Rembold (1990).
An important revelation of the study is that calcium sensitization is linked to stimulation of G
proteins, and potassium depolarization and Bay K8644 are poor activators of G protein-coupled
receptors, at least in vascular smooth muscle.
Although our report is not meant to be a review, we regret that the above cited studies were
not included. We believe that addition of these references will provide our readers with a more
complete history in the search for mechanisms underlying calcium sensitization.
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